Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
PRTA
#2837
Prothena Corporation plc Ordinary Shares
10.6
1
USD
+2.91%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.91%
Changement Mensuel
+14.46%
Evolution sur 6 mois
+4.84%
Changement Annuel
+7.28%
Clôture Précédente
10.3
1
Open
10.6
1
Bid
Ask
Low
10.6
1
High
10.6
1
Volume
51
Marchés
Actions des Marchés US
Soins de Santé
PRTA
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
39.99 M
46.69 M
52.56 M
53.72 M
53.83 M
53.83 M
—
Valuation ratios
Enterprise value
184.87 M
1.73 B
2.1 B
1.45 B
274.12 M
206.57 M
604.6 M
Price to earnings ratio
—
35.8
-21.66
-13.96
-6.1
-2.11
-11.11
Price to sales ratio
—
11.93
42.06
16.76
4.63
21.58
54.79
Price to cash flow ratio
—
25.85
-23.29
-15.32
-4.96
-3.14
-12.72
Price to book ratio
—
5.14
4.07
3.65
1.53
1.83
2.68
Enterprise value to EBITDA ratio
-1.68
23.62
-16.89
-9.12
-2.14
-1.03
-3.85
Profitability ratios
Return on assets %
-0.33
0.11
-0.15
-0.21
-0.22
-0.75
-0.61
Return on equity %
-0.6
0.14
-0.19
-0.26
-0.25
-0.87
-0.73
Return on invested capital %
-891.51
572.42
-866.74
-977.67
-721.49
-1 703.4
-1 546.73
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-5 073.54
35.88
-218.34
-156.1
-96.02
-900.98
-3 549.42
EBITDA margin %
-4 943.79
36.45
-206.57
-130
-79.42
-837.87
-3 267.32
Net margin %
-5 001.98
33.38
-194.09
-120.14
-75.98
-1 024.61
-3 813.19
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
11.58
17.48
14.34
11.24
10.01
7.72
29.01
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.43
0.09
0.17
0.26
0.05
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.91
-2.3
-2.52
-2.79
-3.04
-3.04
EBIT per share
—
1.49
-2.64
-3.01
-2.39
-3.72
-3.72
EBITDA per share
—
1.51
-2.63
-2.99
-2.38
-3.71
-3.71
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
11.95
15
11.63
8.77
5.71
26.52
Net current asset value per share
—
12.07
15.18
12.01
9.03
5.86
27.44
Tangible book value per share
—
9.62
13.13
10.55
9.06
5.21
24.85
Working capital per share
—
11.38
14.12
10.94
8.13
5.1
23.56
Book value per share
—
9.62
13.13
10.55
9.06
5.21
24.85
Nouvelles
Prothena promeut Kingston et Isaacs à des postes de direction
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
H.C. Wainwright réitère sa recommandation sur Prothena suite aux données sur Parkinson
Citizens réitère sa recommandation sur l’action Prothena après une étape clé avec Novo Nordisk
Citizens reaffirms Prothena stock rating on Novo Nordisk milestone
Prothena reçoit 50 millions $ de Novo Nordisk pour un essai clinique
Prothena earns $50M milestone from Novo Nordisk for drug trial
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade